Net Income

Galectin Therapeutics adds legendary neurosurgeon Dr. Henry Brem to its board, a strategic move to leverage his drug development expertise for its lead liver drug.

A new report reveals a stark divide: employers are bullish on growth and AI, but worker confidence is collapsing, putting future productivity at risk.

Two Toledo auto shop sales highlight why investors are flocking to necessity-based real estate, driven by stable income and powerful tax incentives.

In a major strategic move, HSBC appoints Cécile Ratcliffe as CEO of its Continental Europe arm to drive growth in corporate and institutional banking.

Backed by dialysis giants DaVita and U.S. Renal Care, a new startup licenses a first-in-class therapy to transform treatment for kidney patients.

Chinese lifestyle group Atour surpasses growth targets with a 35% revenue jump, fueled by hotel expansion and a booming retail business.

Actress Yolanthe Cabau receives a lifetime award for her NGO's dangerous work rescuing children, but her true mission is turning survivors into advocates.

The world's largest agrochemical expo opens, showcasing a major shift to sustainable solutions and cementing China's central role in global food security.

Food brands are no longer just for eating. Discover how they're conquering fashion and lifestyle, turning taste into a multi-billion dollar empire.

Aqara's new G350 is the first Matter-certified camera, promising universal smart home control. Paired with the G400 doorbell, it's a new era of security.

A Dubai clinic is turning the cosmetic tummy tuck into a medical necessity, offering a surgical solution for chronic back pain caused by muscle separation.

Princess Padmaja Kumari Parmar receives the Mary Tyler Moore Award for her advocacy, bridging a legacy of hope with a modern fight for global T1D equity.

Facing a challenging EV market, Aspen Aerogels looks to the Roth Conference to showcase its long-term growth strategy and advanced aerogel technology.

OTI Lumionics' new method on a single GPU simulates complex molecules in one hour, a task that could take a future quantum computer up to 200 hours.

The newly public BlockchAIn Inc. (AIB) launches with a unique strategy: powering the AI gold rush while also owning a college sports recruitment platform.

The biotech reports promising clinical data for its lead alpha-therapy program and secures funding into late 2027, navigating a high-cost, high-reward path.

Getty Images posts its highest revenue in 30 years, but a massive net loss, shrinking customer base, and a UK merger review cloud its financial future.

With promising clinical data for its lead drug silevertinib and a strong new financial position, Black Diamond Therapeutics charts a dual course for two deadly cancers.

Eve's eVTOL prototype is flying and its finances are secure through 2028, positioning the Embraer-backed company as a top contender in the air taxi race.

A new partnership integrates NVIDIA's high-speed NVQLink, accelerating the race toward fault-tolerant, utility-scale quantum computers.